A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response

BACKGROUND: The optimum second‐line treatment or best sequence of treatments for immune thrombocytopenia (ITP) are yet to be determined. Our institution has accumulated extensive experience regarding the use of dapsone as second‐line therapy for ITP. OBJECTIVES: We aimed to assess the efficacy rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Colella, Marina P., Orsi, Fernanda A., Alves, Elizio C. F., Delmoro, Gabriela de F., Yamaguti‐Hayakawa, Gabriela G., de Paula, Erich V., Annichino‐Bizzacchi, Joyce M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
PLATELETS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456876/
https://www.ncbi.nlm.nih.gov/pubmed/34018665
http://dx.doi.org/10.1111/jth.15396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456876/
https://www.ncbi.nlm.nih.gov/pubmed/34018665
http://dx.doi.org/10.1111/jth.15396

Ejemplares similares